Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas
Status:
Completed
Trial end date:
2017-01-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of food on the single-dose
pharmacokinetics (PK) of alisertib administered as an enteric-coated tablet (ECT) formulation
in participants with advanced solid tumors or lymphomas.